CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $636,000 | -10.0% | 5,367 | -10.3% | 0.00% | -33.3% |
| Q4 2020 | $707,000 | +2.3% | 5,986 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $691,000 | +10.0% | 6,218 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $628,000 | +9.8% | 6,150 | +16.0% | 0.00% | -25.0% |
| Q1 2020 | $572,000 | -41.0% | 5,300 | -36.4% | 0.00% | 0.0% |
| Q4 2019 | $970,000 | -18.2% | 8,331 | -19.6% | 0.00% | -42.9% |
| Q3 2019 | $1,186,000 | +9.5% | 10,358 | -8.9% | 0.01% | +16.7% |
| Q2 2019 | $1,083,000 | -11.2% | 11,365 | -15.0% | 0.01% | -14.3% |
| Q1 2019 | $1,220,000 | +20.4% | 13,372 | +0.2% | 0.01% | 0.0% |
| Q4 2018 | $1,013,000 | -16.7% | 13,340 | -12.2% | 0.01% | -12.5% |
| Q3 2018 | $1,216,000 | -12.1% | 15,197 | +9.1% | 0.01% | -11.1% |
| Q2 2018 | $1,383,000 | +33.8% | 13,925 | +9.1% | 0.01% | +28.6% |
| Q1 2018 | $1,034,000 | -11.8% | 12,765 | -14.2% | 0.01% | -12.5% |
| Q4 2017 | $1,172,000 | -17.2% | 14,875 | -3.0% | 0.01% | -38.5% |
| Q3 2017 | $1,416,000 | – | 15,341 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW SILK ROAD INVESTMENT PTE LTD | 189,395 | $17,476,000 | 9.13% |
| VERNIER CAPITAL PARTNERS, LP | 122,600 | $11,312,000 | 8.31% |
| RUDMAN ERROL M | 26,901 | $2,482,000 | 1.42% |
| HERMES INVESTMENT MANAGEMENT LTD | 712,424 | $65,735,000 | 0.99% |
| Hillhouse Capital Management | 618,391 | $57,059,000 | 0.94% |
| COMGEST GLOBAL INVESTORS S.A.S. | 356,252 | $32,872,000 | 0.76% |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 363,190 | $33,511,000 | 0.26% |
| FIL Ltd | 914,848 | $84,413,000 | 0.24% |
| Gideon Capital Advisors, Inc. | 2,494 | $230,000 | 0.23% |
| WASATCH ADVISORS LP | 137,482 | $12,685,000 | 0.17% |